Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03588273Phase 1Completed
Phase 1, open-label, single-arm trial of amoxicillin in bacterial infection. Primary endpoint: Pharmacokinetic parameters of amoxicillin (Cmax, tmax, AUC, ke, t1/2). Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03588273.